![Thomas Klaue](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Klaue
Amministratore Delegato presso
INJEX Pharma AG
Profilo
Thomas Klaue currently works at INJEX Pharma AG, as Chief Executive Officer from 2013 and Siqens GmbH, as Chief Executive Officer from 2022.
Dr. Klaue also formerly worked at MediGene AG, as Chief Financial Officer.
Posizioni attive di Thomas Klaue
| Società | Posizione | Inizio |
|---|---|---|
INJEX Pharma AG
 INJEX Pharma AG Medical SpecialtiesHealth Technology Manufactures needle free injection equipment | Amministratore Delegato | 30/06/2013 |
Siqens GmbH
 Siqens GmbH Electronic Production EquipmentElectronic Technology Provides methanol fuel cells and electrochemical hydrogen capture technologies | Amministratore Delegato | 01/07/2022 |
Precedenti posizioni note di Thomas Klaue
| Società | Posizione | Fine |
|---|---|---|
| MEDIGENE AG | Direttore Finanziario/CFO | 19/04/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
MediGene AG
 MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
INJEX Pharma AG
INJEX Pharma AG Medical SpecialtiesHealth Technology Manufactures needle free injection equipment | Health Technology |
Siqens GmbH
Siqens GmbH Electronic Production EquipmentElectronic Technology Provides methanol fuel cells and electrochemical hydrogen capture technologies | Electronic Technology |
